What is the blood pressure goal for the elder patient 75 years of age or older?

Current Cardiology Reports

Volumn 13, Issue 6, 2011, Pages 485-491

  Sander, Gary E ^a   Giles, Thomas D ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood pressure goal; Elderly hypertensive patients; Hypertension treatment; Pitfalls of hypertension management in the elderly; Resistant hypertension in the elderly

Indexed keywords

CHLORTALIDONE; INDAPAMIDE; PERINDOPRIL; PLACEBO;

AGING; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; COMORBIDITY; DIASTOLIC BLOOD PRESSURE; HUMAN; HYPERTENSION; METABOLIC PARAMETERS; PATHOPHYSIOLOGY; PATIENT IDENTIFICATION; PATIENT SELECTION; SIDE EFFECT; SODIUM RESTRICTION; STROKE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; WEIGHT REDUCTION; WHITE COAT HYPERTENSION;

AGED; AGED, 80 AND OVER; AGING; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYPERTENSION; MALE; PHENOTYPE; RISK FACTORS;

EID: 81255137888     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-011-0222-1     Document Type: Article

References (47)

1. NS Beckett R Peters AE Fletcher, et al. 2008 Treatment of hypertension in patients 80 years of age or older N Engl J Med 358 1887 1898 18378519 10.1056/NEJMoa0801369 1:CAS:528:DC%2BD1cXlt1Ggsbk%3D This is the HYVET study, the first clinical trial clearly demonstrating a reduction in cardiovascular event rate in patients ages 75 years or older
2. WS Aronow JL Fleg CJ Carl Pepine, et al. 2011 ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly J Am Coll Cardiol 57 2037 2114 21524875 10.1016/j.jacc.2011.01.008 This document is an extremely detailed and definitive review of the literature and of treatment considerations of elevated BP in the "elderly"; this is the ultimate reference for information concerning this topic
3. J Stokes III WB Kannel PA Wolf, et al. 1989 Blood pressure as a risk factor for cardiovascular disease: the Framingham Study-30 years of follow-up Hypertension. 13 I13 I18 2535213
4. S Lewington R Clarke N Qizilbash, et al. 2002 Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies Lancet. 360 1903 1913 12493255 10.1016/S0140-6736(02)11911-8
5. The fifth report of the Joint National Committee on Detection 1993 Evaluation, and treatment of high blood pressure (JNC V) Arch Intern Med 153 154 183 10.1001/archinte.153.2.154
6. AV Chobanian GL Bakris HR Black, et al. 2003 National heart, lung, and blood institute joint national committee on prevention, detection, evaluation, and treatment of high BP. National high BP education program coordinating committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high BP: the JNC 7 report JAMA 289 2560 2572 12748199 10.1001/jama.289.19.2560 1:CAS:528:DC%2BD3sXjvFCqtrk%3D
7. B Williams NR Poulter MJ Brown, et al. 2004 BHS guidelines working party, for the british hypertension society. british hypertension society guidelines for hypertension management 2004 (BHS-IV): summary BMJ 328 634 640 15016698 10.1136/bmj.328.7440.634
8. D Lloyd-Jones R Adams M Carnethon, et al. 2009 Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation. 119 e21 e181 19075105 10.1161/CIRCULATIONAHA.108.191261
9. National High BP Education Program Working Group 1994 National High BP Education Program Working Group report on hypertension in the elderly Hypertension 23 275 285
10. A Benetos F Thomas K Bean, et al. 2002 Prognostic value of systolic and diastolic blood pressure in treated hypertensive men Arch Inter Med 162 577 581 10.1001/archinte.162.5.577
11. WL Oui S Barrett M Houssain, et al. 1997 Patterns of orthostatic BP change and their clinical correlates in a frail, elderly population JAMA 277 1299 1304 10.1001/jama.277.16.1299
12. M Moser JF Setaro 2006 Resistant or difficult-to-control hypertension N Engl J Med 355 385 392 16870917 10.1056/NEJMcp041698 1:CAS:528: DC%2BD28XntlSjuro%3D This review article details the difficulties and considerations in the evaluation and treatment of resistant hypertension, a particularly serious problem for the elderly
13. P Trenkwalder M Plaschke I Steffes-Tremer, et al. 1993 "White-coat" hypertension and alerting reaction in elderly and very elderly hypertensive patients Blood Press. 2 262 271 8173694 10.3109/08037059309077166 1:STN:280:DyaK2c3isl2qsQ%3D%3D
14. SL Rasmussen C Torp-Pedersen K Borch-Johnsen, et al. 1998 Normal values for ambulatory blood pressure and differences between casual blood pressure and ambulatory blood pressure: results from a Danish population survey J Hypertens. 16 1415 1424 9814611 10.1097/00004872-199816100-00004 1:STN:280: DyaK1M%2FivFOnug%3D%3D
15. ED Manios EA Koroboki GK Tsivgoulis, et al. 2008 Factors influencing white-coat effect Am J Hypertens. 21 153 158 18174883 10.1038/ajh.2007.43
16. M Jumabay Y Ozawa H Kawamura, et al. 2005 White coat hypertension in centenarians Am J Hypertens. 18 1040 1045 16109317 10.1016/j.amjhyper.2005.03. 732
17. N Wiinberg A Hoegholm HR Christensen, et al. 1995 24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender Am J Hypertens. 8 978 986 8845079 10.1016/0895-7061(95)00216-2 1:STN:280: DyaK287ht1eqsg%3D%3D
18. JA Staessen L Thijs R Fagard, et al. 1999 Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension: Systolic Hypertension in Europe Trial Investigators JAMA. 282 539 546 10450715 10.1001/jama.282.6.539 1:STN:280:DyaK1Mznsl2htg%3D%3D
19. ML Burr E Dolan EW O'Brien, et al. 2008 The value of ambulatory blood pressure in older adults: the Dublin outcome study Age Ageing 37 201 206 18349014 10.1093/ageing/afm193 This is a study from one center of 1144 subjects ages ≥ 65 years demonstrating that ambulatory BP monitoring and in particular nighttime BP is superior to clinic measurement in predicting cardiovascular mortality in elderly subjects
20. LM Wing MA Brown LJ Beilin, et al. 2002 Reverse white-coat hypertension in older hypertensives J Hypertens. 20 639 644 11910298 10.1097/00004872- 200204000-00020 1:CAS:528:DC%2BD38XmvFCnu70%3D
21. G Bobrie G Chatellier N Genes, et al. 2004 Cardiovascular prognosis of "masked hypertension" detected by BP self-measurement in elderly treated hypertensive patients JAMA 291 1342 1349 15026401 10.1001/jama.291.11. 1342 1:CAS:528:DC%2BD2cXitlKntrs%3D
22. MD Fotherby JF Potter 1995 Twenty-four-hour ambulatory BP in old and very old subjects J Hyperten 13 12 Pt 2 1742 1746 1:STN:280:DyaK2s%2FlvFehsQ%3D%3D
23. GS Stokes 2004 S hypertension in the elderly: pushing the frontiers of therapy - a suggested new approach J Clin Hypertens 6 192 197 10.1111/j.1524-6175.2004.03508.x
24. WW Nichols FA Nicolini CJ Pepine 1992 Determinants of isolated systolic hypertension in the elderly J Hypertens. 10 suppl 6 S73 S77 1:STN:280: DyaK3s%2FlvVSlsg%3D%3D
25. GF Mitchell Y Lacourciere JP Ouellet, et al. 2003 Determinants of elevated pulse pressure in middle-aged and older subjects with uncomplicated S hypertension: the role of proximal aortic diameter and the aortic pressure-flow relationship Circulation. 108 1592 1598 12975261 10.1161/01.CIR.0000093435. 04334.1F
26. SS Franklin WG Gustin ND Wong, et al. 1997 Hemodynamic patterns of age-related changes in BP: the Framingham Heart Study Circulation. 96 308 315 9236450 1:STN:280:DyaK2sznvFKmsw%3D%3D
27. MG Crane JJ Harris 1976 Effect of aging on renin activity and aldosterone secretion J Lab Clin Med 87 947 959 932525 1:CAS:528:DyaE28XksVChur0%3D
28. Abraham K, Lowenthal DT. Hypertension in the elderly. In: Hypertension: A Companion to Brenner and Rector's The Kidney. Edited by Oparil S and Weber MA. Philadelphia; W.B. Saunders 2000:551-58.
29. MB Zemel J Sowers 1988 Salt sensitivity and systemic hypertension in the elderly Am J Cardiol. 61 7H 12H 3289354 10.1016/0002-9149(88)91098-3 1:STN:280:DyaL1c3ltVSrtQ%3D%3D
30. WB Applegate BR Davis HR Black, et al. 1991 Prevalence of postural hypotension at baseline in the Systolic Hypertension in the Elderly Program (SHEP) cohort J Amer Geriatr Soc 39 1057 1064 1:STN:280:DyaK38%2FptFKhtg%3D%3D
31. E Paran O Anson H Reuveni 2003 BP and cognitive functioning among independent elderly J Hypertens 16 818 826 10.1016/S0895-7061(03)01005-7
32. JB Kostis MA Espeland L Appel, et al. 1998 Does withdrawal of antihypertensive medication increase the risk of cardiovascular events? Trial of Nonpharmacologic Interventions in the Elderly (TONE) Cooperative Research Group Amer J Cardiol. 82 1501 1508 9874055 10.1016/S0002-9149(98)00694-8 1:STN:280:DyaK1M%2FovFCmsw%3D%3D
33. GE Sander 2002 High BP in the geriatric population: treatment considerations Am J Geriatr Cardiol 11 223 232 12091771 10.1111/j.1076-7460. 2002.00032.x 1:STN:280:DC%2BD38zkvVSjsw%3D%3D
34. JA Staessen J Gasowski JG Wang, et al. 2000 Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials Lancet 355 865 872 10752701 10.1016/S0140-6736(99)07330-4 1:STN:280:DC%2BD3c3hsVektw%3D%3D
35. S MacMahon A Rodgers 1993 The effects of BP reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives Clin Exp Hypertens (New York) 15 967 978 10.3109/10641969309037085 1:STN:280:DyaK2c%2FptlGgsg%3D%3D
36. CJ Pepine EM Handberg RM Cooper-DeHoff, et al. 2003 For the INVEST Investigators. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial JAMA 290 2805 2816 14657064 10.1001/jama.290.21.2805 1:CAS:528:DC%2BD3sXps1Crurk%3D
37. SJ Denardo Y Gong WW Nichols, et al. 2010 Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INternational VErapamil ST-Trandolapril (INVEST) substudy Am J Med 123 719 726 20670726 10.1016/j.amjmed.2010.02.014 This study nicely describes the "J-curve" noted in the elderly in the INVEST study, demonstrating that optimal management of hypertension in elderly coronary artery disease patients may involve targeting specific SBPs and DBPs that are higher and somewhat lower, respectively, compared with other age groups
38. K Jamerson MA Weber GL Bakris, et al. 2008 For the ACCOMPLISH Trial Investigators. Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients N Engl J Med 359 2417 2428 19052124 10.1056/NEJMoa0806182 1:CAS:528:DC%2BD1cXhsVCrurjJ
39. WC Cushman GW Evans RP Byington, et al. 2010 Effects of intensive blood-pressure control in type 2 diabetes mellitus N Engl J Med. 362 1575 1585 20228401 10.1056/NEJMoa1001286
40. •• Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009;27:2121-58.2010;362:1575-85. This is the European perspective on evaluation and treatment of hypertension.
41. PJ Savage SL Pressel JD Curb, et al. 1998 Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group Arch Intern Med 158 741 751 9554680 10.1001/archinte.158.7.741 1:CAS:528:DyaK1cXislCjsbo%3D
42. LV Franse M Pahor M DiBari, et al. 2000 Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program Hypertension 35 1025 1030 10818057 1:STN:280: DC%2BD3c3nvF2gsw%3D%3D
43. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981-97.
44. P Verdecchia G Reboldi F Angeli, et al. 2004 Adverse prognostic significance of new diabetes in treated hypertensive subjects Hypertension 43 963 969 15037557 10.1161/01.HYP.0000125726.92964.ab 1:CAS:528: DC%2BD2cXjt1Gmsb8%3D
45. P Raheja D Arbique Z Wang, et al. 2011 Spironolactone reverses chlorthalidone-induced sympathetic activation in hypertensive patients J Clin Hypertens 13 Suppl 1 OR-6
46. FH Messerli G Mancia CR Conti, et al. 2006 Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med. 144 884 893 16785477
47. F Forette ML Seux JA Staessen, et al. 1998 Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial Lancet 352 1347 1351 9802273 10.1016/S0140-6736(98)03086-4 1:STN:280:DyaK1M%2Fhslamuw%3D%3D